Opzelura goes global
Vitiligo, a chronic autoimmune disorder that causes patches of skin to lose pigment or color, has confounded the medical field for the vast majority […]
Opzelura goes global Read More »
Vitiligo, a chronic autoimmune disorder that causes patches of skin to lose pigment or color, has confounded the medical field for the vast majority […]
Opzelura goes global Read More »
On Friday, U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, ordered a hold on federal approval of mifepristone, a drug approved by the U.S.
Texas mifepristone ruling undermines FDA approval process, experts say Read More »
For National Public Health Week, the Biotechnology Innovation Organization (BIO) is talking to Deborah Levine, Director at the City of New York Graduate School
Community involvement is key to effective public health Read More »
The Black Coalition Against COVID (BCAC) was born on Easter Sunday 2020. Dr. Reed Tuckson, the organization’s co-founder recalls, “We looked at the data
On Wednesday, Moderna’s CEO will testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in a hearing with a misleading title, “Taxpayers
4 questions with Moderna President Stephen Hoge Read More »
The importance of data and the growing use of technology – such as wearables and other mobile devices and sensors that can collect and
How biotech is addressing sources of bias in studies using real-world evidence Read More »
The third anniversary of the COVID-19 pandemic on March 11 may feel to some like a relief as we transition into a post-COVID era.
As the COVID pandemic turns 3, are we ready for the next one? Read More »
In healthcare, business development (BD) is one of our most powerful tools to accelerate scientific innovation. In an industry where companies often race for
3 key insights to fostering successful collaboration in women’s health Read More »
Already, 2023 is looking like a dynamic year for biotech on the state level as state legislatures nationwide get ready to tackle a few
4 things for biotech to watch in the 2023 state legislatures Read More »
The Inflation Reduction Act’s drug price controls have been a hot topic during the BIO CEO and Investor Conference—and one that has hampered an
We’re already seeing the impact of drug price controls, say biotech CEOs Read More »